These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 825358)

  • 1. Equivalency of two lots of heparin and their effects on various coagulation tests.
    Heinrich RA; Smith TC; Moyer CE
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):725-34. PubMed ID: 825358
    [No Abstract]   [Full Text] [Related]  

  • 2. The intra-arterial line: a site for obtaining coagulation studies.
    Pryor AC
    Heart Lung; 1983 Nov; 12(6):586-90. PubMed ID: 6556170
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of lepra reaction.
    Mukherjee A; Ghosh S
    Int J Lepr Other Mycobact Dis; 1974; 42(2):143-9. PubMed ID: 4473431
    [No Abstract]   [Full Text] [Related]  

  • 4. [Control of heparin and oral anticoagulants, with micromethods: thrombin time, quick determination with addition of protamine].
    Seiler K; Müller G; Duckert F
    Schweiz Med Wochenschr; 1970 Sep; 100(36):1522-8. PubMed ID: 5524716
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of low molecular weight heparin on the hemostatic system after abdominal surgery.
    Schmitz-Huebner U; Rüschemeyer C; Schulte H; van de Loo J
    Thromb Haemost; 1985 Jun; 53(3):297-300. PubMed ID: 3901387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of some indices of blood coagulation and anticoagulation system in acute bacillary dysentery].
    Keshishian SG
    Zh Eksp Klin Med; 1969; 9(3):67-70. PubMed ID: 5376525
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rapid tests for diagnosis of coagulation disturbances. Results of a clinical trial].
    Norén I; Blombäck M
    Nord Med; 1969 Oct; 82(41):1277-83. PubMed ID: 5354534
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of aprotinin on heparinized whole blood activated clotting time and whole blood prothrombin time].
    Wen Z; Zhu F; He X; Xiong S; He S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):304-6. PubMed ID: 9868081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on blood coagulation in cancer patients.
    Dube B; Khanna MN; Kulkarni BJ
    Am Surg; 1974 Oct; 40(10):264-70. PubMed ID: 4415934
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 13. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of various methods of heparin treatment].
    Chojnowski K; Judkiewicz L; Ciszewski R; Majda J
    Pol Tyg Lek; 1985 Nov; 40(44):1232-4. PubMed ID: 3911186
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations.
    Rhodes GR; Dixon RH; Silver D
    Surg Gynecol Obstet; 1973 Mar; 136(3):409-16. PubMed ID: 4688805
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin-induced inhibitory effects of a prothrombin complex concentrate on global tests of haemostasis.
    Takeyama M; Sakurai Y; Shima M; Matsumoto T; Nogami K; Tanaka I; Takeda T; Giddings JC; Yoshioka A
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):1-7. PubMed ID: 17179819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic problems of disseminated intravascular coagulation.
    Sherman LA; Wessler S; Avioli LV
    Arch Intern Med; 1973 Sep; 132(3):446-53. PubMed ID: 4783026
    [No Abstract]   [Full Text] [Related]  

  • 19. ["Heparin rebound" and fibrinolytic activity in extracorporeal circulation (author's transl)].
    Sanz MA; Aznar JA; Tascón A; Martínez J; Marty ML
    Sangre (Barc); 1977; 22(3):346-50. PubMed ID: 867212
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficiency and limits of blood coagulation tests].
    Róka L
    Internist (Berl); 1973 Apr; 14(4):149-53. PubMed ID: 4577209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.